Dupilumab in patients with moderate to severe atopic dermatitis and multiple sclerosis

• Maria Esposito, MD,
• Andrea De Berardinis, MD,
• Rocco Totaro, MD,
• Maria Concetta Fargnoli, MD

Affiliations

Maria Esposito, MD

Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy; Correspondence to: Maria Esposito, MD, Dermatology, Department of Biotechnological ad Applied Clinical Sciences, University of L’Aquila, via Vetoio-Coppito 2, 67100, L’Aquila, Italy.

Andrea De Berardinis, MD

Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy

Rocco Totaro, MD

Department of Neurology, Multiple Sclerosis Center, San Salvatore Hospital, L'Aquila, Italy

Maria Concetta Fargnoli, MD

Dermatology, Department of Biotechnological and Applied Clinical Sciences, University of L’Aquila, L’Aquila, Italy